Patient Capital Bet Heavily on Chime Financial (CHYM) With a 2.04 Million Share Purchase

2 hours ago 2

Cory Renauer, The Motley Fool

Sat, February 14, 2026 astatine 2:05 PM CST 4 min read

According to a Securities and Exchange Commission (SEC) filing dated Feb. 13, 2026, Patient Capital Management, LLC initiated a caller presumption successful Chime Financial (NASDAQ:CHYM), acquiring astir 2,035,112 shares during the 4th quarter. The estimated transaction worth was $51.22 million, calculated utilizing mean quarterly pricing. The quarter-end worth of the holding roseate by $51.22 million, arsenic the presumption was recently established during the period.

This was a caller presumption for the fund, with the post-trade holding accounting for 1.98% of reportable AUM arsenic of Dec. 31, 2025
Top holdings aft the filing:
- NASDAQ: GOOGL: $182.05 cardinal (7.0% of AUM)
- NYSE: C: $150.74 cardinal (5.8% of AUM)
- NASDAQ: AMZN: $129.85 cardinal (5.0% of AUM)
- NASDAQ: RPRX: $128.81 cardinal (5.0% of AUM)
- NYSE: QXO: $124.78 cardinal (4.8% of AUM)
As of the astir caller disposable data, shares of Chime Financial were priced astatine $19.69; one-year banal terms alteration and alpha versus the S&P 500 were not available

Metric

Value

Price (as of marketplace adjacent February 13, 2026)	$19.69
Market capitalization	$7.38 billion
Revenue (TTM)	$1.67 billion
Net income (TTM)	($25.34 million)

Offers mobile-first, fee-free banking services including checking, savings, aboriginal paycheck access, and overdraft protection, delivered via partnerships with FDIC-insured banks.
Generates gross chiefly from interchange fees connected debit paper transactions, leveraging a integer level to minimize operating costs.
Targets U.S. consumers earning nether $100,000 per year, focusing connected individuals seeking accessible, low-cost banking solutions.

Chime Financial is simply a starring U.S. fintech level specializing successful integer banking for mass-market consumers. The institution operates astatine standard with implicit $1.67 cardinal successful trailing 12 months gross and a marketplace capitalization of $7.38 cardinal arsenic of Feb. 13, 2026. Its strategy centers connected fee-free banking and user-friendly integer experiences, positioning Chime arsenic a disruptive unit among determination banks and accepted fiscal institutions.

Patient Capital made 2 caller additions to its portfolio successful the past 3 months of 2025. The fund’s different caller summation was besides successful the Fintech space. In summation to Chime Financial, Patient Capital added 259,161 shares of Fiserv (NASDAQ:FISV), a ample planetary payments processor.

Chime Financial expects to study fourth-quarter results connected Feb. 25 aft the marketplace closes. Patient Capital volition person fingers crossed for continued maturation astatine an awesome pace. During the 3 months ended September 2025, the institution reported income that grew by 29% twelvemonth implicit year. Over the aforesaid clip frame, the fig of progressive members utilizing its fiscal services grew by 21% to scope 9.1 million.

Read Entire Article